Publicacions destacades

Efficacy of Elbasvir/Grazoprevir in Early Chronic G1/G4 Hepatitis C infection in HIV/HCV co-infected patients with mild fibrosis

Laguno Centeno M; Alvarez B; Martínez-Rebollar M; de la Mora L; Prieto L;

(...)

González-Cordón A; Torres B; Cabello A; Gorgolas M; Mallolas J .

Referència:
Gastroenterologia Y Hepatologia 2021.
Primary HIV-1 infection in users of pre-exposure prophylaxis

Ambrosioni J; Petit E; Liegeon G; Laguno M; Miró JM ;

Referència:
Lancet Hiv 2021.
Immunological and virological efficacy of different antiretroviral regimens initiated during acute/recent HIV infection

Ambrosioni J; Farrera J; de Lazzari E; Nicolás D; Manzardo C;

(...)

Sánchez-Palomino S; Fernández E; Plana M; Miró JM; Hospital Clinic Acute/Recent HIV Study Group.

Referència:
Aids 2020.
Clinical characteristics, risk factors, and incidence of symptomatic COVID-19 in adults living with HIV: a single-center, prospective observational study

Inciarte A; Gonzalez-Cordon A; Rojas J; Torres B; de Lazzari E;

(...)

Ambrosioni J; Miro JM; Martinez E; Blanco JL; (on behalf the COVID-19 in HIV Investigators).

Referència:
Aids 2020.
Recommendations for measuring HIV reservoir size in cure-directed clinical trials

Abdel-Mohsen M; Richman D; Siliciano RF; Nussenzweig MC; Howell BJ;

(...)

Frank I; Riley JL; Tebas P; Montaner LJ; BEAT-HIV Delaney Collaboratory to Cure HIV-1 infection.

Referència:
Nature Medicine 2020.
COVID-19 in patients with HIV: clinical case series

Blanco JL; Ambrosioni J; Garcia F; Martínez E; Soriano A;

Mallolas J; Miro JM.

Referència:
Lancet Hiv 2020.
A 24-week pilot study of dual maintenance therapy with raltegravir and lamivudine

de Lazzari E; Lonca M; Rojas J; Gonzalez-Cordon A; Blanch J;

(...)

Mallolas J; Sanchez-Palomino S; Plana M; Blanco JL; Martinez E .

Referència:
Aids 2019.
Time to change cardiovascular prevention in people with HIV

Martinez E;

Referència:
Lancet Hiv 2019.